Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Dược Lực Học :
Cholesterol is probably the sole precursor of bile acids. During normal digestion, bile acids are secreted into the intestines. A major portion of the bile acids is absorbed from the intestinal tract and returned to the liver via the enterohepatic circulation. Only very small amounts of bile acids are found in normal serum. Cholestyramine resin adsorbs and combines with the bile acids in the intestine to form an insoluble complex which is excreted in the feces. This results in a partial removal of bile acids from the enterohepatic circulation by preventing their absorption.
Cơ Chế Tác Dụng :
Cholestyramine or colestyramine is a bile acid sequestrant. Bile acid sequestrants are polymeric compounds which serve as ion exchange resins. Cholestyramine resin is quite hydrophilic, but insoluble in water.
Cholestyramine binds bile in the gastrointestinal tract to prevent its reabsorption. The resin is a strong anion exchange resin, which means that it can exchange its chloride anions with anionic bile acids in the gastrointestinal tract and bind them strongly in the resin matrix. The functional group of the anion exchange resin is a quaternary ammonium group attached to an inert styrene-divinylbenzene copolymer.
Dược Động Học :
▧ Absorption :
Not absorbed from the gastrointestinal tract following oral administration.
▧ Metabolism :
Bile acids
▧ Route of Elimination :
Cholestyramine resin adsorbs and combines with the bile acids in the intestine to form an insoluble complex which is excreted in the feces.
▧ Half Life :
6 minutes
Độc Tính :
Overdose may result in blockage of intestine or stomach.
Chỉ Định :
Indicated as adjunctive therapy to diet for the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia (elevated low density lipoprotein [LDL] cholesterol) who do not respond adequately to diet. Also for the relief of pruritus associated with partial biliary obstruction.
Tương Tác Thuốc :
-
Acenocoumarol
The bile acid sequestrant, cholestyramine, may decrease the anticoagulant effect of acenocoumarol by decreasing its absorption.
-
Anisindione
The bile acid sequestrant, cholestyramine, may decrease the anticoagulant effect of anisindione by decreasing its absorption.
-
Bezafibrate
Bile acid sequestrants like cholestyramine may decrease the absorption of fibric acid derivatives like bezafibrate. Therapy modification should be considered. If concomitant therapy is used, separate doses by at least 2 hours to minimize this interaction. Fenofibric acid labeling recommends administration one hour prior to or 4-6 hours after a bile acid sequestrant.
-
Chlorothiazide
Bile acid sequestrants may decrease the absorption of thiazide diuretics such as chlorothiazide. The diuretic response is likewise decreased. Monitor for decreased therapeutic effects of thiazide diuretics if coadministered with a bile acid sequestrant. If these agents are used concomitantly, separate doses 2 or more hours to minimize the interaction.
-
Cholecalciferol
Bile acid sequestrants such as cholestyramine may decrease the serum concentration of Vitamin D analogs such as cholecalciferol. More specifically, bile acid sequestrants may impair absorption of Vitamin D analogs. Avoid concomitant administration of vitamin D analogs and bile acid sequestrants. Monitor plasma calcium concentrations in patients receiving combined therapy with these agents. This is particularly important in patients receiving higher doses of a bile acid sequestant (i.e., 30 g/day or more of cholestyramine or equivalent) or in patients experiencing bile acid sequestrant-induced steatorrhea. Specific recommendations regarding the separation of administration of these agents are not defined; however, it would seem prudent to separate the administration of these agents by several hours to minimize the potential risk of interaction. Similar precautions do not apply to parenterally administered vitamin D analogs.
-
Dicoumarol
The bile acid sequestrant, cholestyramine, may decrease the anticoagulant effect of dicumarol by decreasing its absorption.
-
Digoxin
The resin decreases the effect of digoxin
-
Ezetimibe
Cholestyramine may decrease the levels of ezetimibe.
-
Fluvastatin
Increased/decreased effect according to spacing
-
Hydrocortisone
Cholestyramine may decrease the effect of hydrocortisone.
-
Levothyroxine
The resin, cholestyramine, decreases the absorption of the thyroid hormone, levothyroxine.
-
Liothyronine
The resin, cholestyramine, decreases the absorption of the thyroid hormones, liothyronine.
-
Liotrix
The resin, cholestyramine, decreases the absorption of the thyroid hormone, liotrix.
-
Lomitapide
Bile acid sequestrants also used for treating high cholesterol may interfere with the absorption of oral medications, thus separate administration by 4 hours.
-
Methotrexate
Decreased levels of methotrexate
-
Raloxifene
The resin decreases the effect of raloxifene
-
Spironolactone
Increased risk of acidosis and hyperkalemia
-
Sulindac
The bile acid sequestrant, cholestyramine, may decrease the absorption of the NSAID, sulindac. Monitor for changes in the therapeutic and adverse effects of sulindac if cholestyramine is initiated, discontinued or dose changed. Administering the two agents 2 or more hours apart may reduce, but not eliminate, the risk of this interactions.
-
Tenoxicam
Cholestyramine may decrease the serum concentration of Tenoxicam by increasing clearance. Monitor for changes in Tenoxicam therapeutic and adverse effects if Cholestyramine is initiated, discontinued or dose changed.
-
Thyroglobulin
The resin, cholestyramine, decreases the absorption of the thyroid hormone, thyroglobulin.
-
Tiaprofenic acid
The bile acid sequestrant, Cholestyramine resin, may reduce Tiaprofenic acid absorption and therapeutic effect.
-
Tolmetin
Cholestyramine may decrease the absorption of Tolmetin. Monitor for changes in the therapeutic and adverse effects of Tolmetin if Cholestyramine is initiated, discontinued or dose changed. Spacing administration by at least 2 hours may reduce the risk of interaction.
-
Torasemide
Cholestyramine may decrease the bioavailability of Torasemide by inhibiting Torasemide absorption. Monitor for changes in the therapeutic and adverse effects of Torasemide if Cholestyramine is initiated, discontinued or dose changed. Spacing administration by at least 2 hours may reduce the risk of interaction.
-
Trichlormethiazide
The bile acid sequestrant, Cholestyramine resin, may inhibit the absorption of Trichlormethiazide.
-
Troglitazone
Decreases the effect of troglitazone
-
Ursodeoxycholic acid
The resin decreases the effect of ursodiol
-
Warfarin
The bile acid sequestrant, cholestyramine, may decrease the anticoagulant effect of warfarin by decreasing its absorption.
Liều Lượng & Cách Dùng :
Powder - Oral
Powder, for solution - Oral
Powder, for suspension - Oral
Dữ Kiện Thương Mại
Giá thị trường
-
Giá bán buôn : USD >1.41
Đơn vị tính : packet
-
Giá bán buôn : USD >1.41
Đơn vị tính : packet
-
Giá bán buôn : USD >2.58
Đơn vị tính : each
-
Giá bán buôn : USD >3.35
Đơn vị tính : each
-
Giá bán buôn : USD >3.49
Đơn vị tính : packet
-
Giá bán buôn : USD >3.5
Đơn vị tính : packet
-
Giá bán buôn : USD >4.23
Đơn vị tính : each
-
Giá bán buôn : USD >4.25
Đơn vị tính : each
-
Giá bán buôn : USD >4.4
Đơn vị tính : packet
-
Giá bán buôn : USD >16.83
Đơn vị tính : g
-
Giá bán buôn : USD >57.99
Đơn vị tính : can
-
Giá bán buôn : USD >57.99
Đơn vị tính : can
-
Giá bán buôn : USD >102.35
Đơn vị tính : can
-
Giá bán buôn : USD >115.62
Đơn vị tính : can
-
Giá bán buôn : USD >116.3
Đơn vị tính : can
Nhà Sản Xuất
-
Sản phẩm biệt dược : Cholybar
-
Sản phẩm biệt dược : Locholest
-
Sản phẩm biệt dược : Locholest light
-
Sản phẩm biệt dược : Prevalite
-
Sản phẩm biệt dược : Questran
-
Sản phẩm biệt dược : Questran Light
Tài Liệu Tham Khảo Thêm
National Drug Code Directory